Guest guest Posted October 29, 2010 Report Posted October 29, 2010 Dear D, This Research & Treatment News update gives you highlights from the latest articles posted to Hepatitis-Central.com for patients and their families, caregivers and health professionals. With new information being published regularly, we want you to have the latest news on treatments, clinical trials, social issues and important breakthroughs. Why Hepatitis C Patients Should Practice Diabetes Prevention November is National Diabetes Awareness Month. By analyzing relevant research, it appears that diabetes prevention efforts may protect Hepatitis C previous non-responders from developing liver cancer. Read more. Nitazoxanide and IC41 Take on Interferon and Ribavirin Intercell’s investigational, therapeutic Hepatitis C vaccine, IC41, and Romark’s antiviral drug, nitazoxanide, will be studied together to see if their effectiveness at fighting Hepatitis C can top the current standard of treatment – pegylated interferon and ribavirin. Read more. Unique Oral Drug Combo Acknowledged as Potential Hepatitis C Therapy A small study found that combining two oral drugs (not including interferon or ribavirin) demonstrated potential in treating Hepatitis C without many serious adverse events. Read more. New Study Finds Hepatitis C Capable of Hurting Brain Cells Helping to bring a new level of understanding to the Hepatitis C virus (HCV), a University of Alberta study found that this infection can affect neural cells. Besides helping explain some common Hepatitis C symptoms, these findings could pave the way for a new frontier in HCV treatment. Read more. New Hepatitis C Drugs Could Use Fat Enzyme Inhibition Thanks to a discovery that fat is involved in Hepatitis C replication, new therapies targeting inhibition of the implicated fat enzyme could successfully combat the Hepatitis C virus. Read more. Chronic Hepatitis C Sufferers Might Benefit from Eurythmy Learn why eurythmy therapy, a component of anthroposophic medicine, may help those with Hepatitis C by delivering an active approach toward liver wellness. Read more. Human Cells in Mice Provide New Model for Studying HCV By engineering mice livers to contain enough human cells, researchers at the Salk Institute for Biological Studies are making progress in the quest to find better therapeutic solutions for many ailments, including Hepatitis C. Read more. Your Opinion Wanted: Did you know before reading “Why Hepatitis C Patients Should Practice Diabetes Prevention,†that Hepatitis C interferon therapy non-responders are at high risk for developing adult onset diabetes? YesNo VISIT the Diabetes poll today. We asked, you responded: The following five strategies can help reduce the severity and length of a cold or flu without posing any risks to a liver with Hepatitis C. Which strategy do you use most often? 30%: Taking vitamin c to help ward off illness. 6%: Gargling with salt water to ease throat pain and inflammation.4%: Breathing in steam to keep mucous membranes moist and break up congestion.5%: Taking zinc to increase the production of disease-fighting white blood cells.5%: Supplementing with N-Acetyl Cysteine (NAC) to help the liver breakdown hazardous compounds.34%: All of the Above.16%: None of the Above. To learn even more about Hepatitis C and what you can do about it, visit Hepatitis-Central.com. You'll find more than 2,750 pages of in-depth information for HCV patients and their families, caregivers and health professionals. If you would like to review an article you saw in one of these recent Research & Treatment News updates, or would like to search through any of the archived, in-depth news and commentary pages, you ought to browse Hepatitis C Information Central at Hepatitis-Central.com. Note: LiverSupport Health News, our “sister†e-newsletter, gives you valuable lifestyle suggestions and news-you-can-use from our LiverSupport.com editors. Just click here to sign up for LiverSupport Health News, and learn even more about supporting liver health for you and your family. Yours in health,Editors@...www.Hepatitis-Central.com1-800-364-5722 Do you have a friend or relative who would find the information in this Research & Treatment News update useful? You can forward this email to them, so they can begin reading all the latest hepatitis research and liver support news. If you're not a current subscriber, click here to sign up today. We value your privacy. We will not rent your e-mail to anyone. Review our Privacy Policy. ©2010 Hepatitis-Central.com. Hepatitis-Central.com2331 State Route 17KMontgomery, NY 125491-800-364-5722 Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.